Finch Therapeutics Group Inc
OTC:FNCH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Finch Therapeutics Group Inc
OTC:FNCH
|
US |
|
Reckitt Benckiser Group PLC
LSE:RKT
|
UK |
|
C
|
China Medical System Holdings Ltd
OTC:CHSYF
|
CN |
|
ALLETE Inc
NYSE:ALE
|
US |
|
A
|
ARC Resources Ltd
OTC:AETUF
|
CA |
|
Lion Copper and Gold Corp
XTSX:LEO
|
CA |
|
Tomra Systems ASA
OSE:TOM
|
NO |
|
Nuvoco Vistas Corporation Ltd
NSE:NUVOCO
|
IN |
|
N
|
Nexgen Energy Ltd
NYSE:NXE
|
CA |
|
Bank of the Philippine Islands
OTC:BPHLY
|
PH |
|
I
|
IST Ltd
BSE:508807
|
IN |
|
I
|
Igloo Corp
KOSDAQ:067920
|
KR |
|
Scatec ASA
OSE:SCATC
|
NO |
|
A
|
ACS Actividades de Construccion y Servicios SA
XMUN:OCI1
|
ES |
|
A
|
Aramis Group SAS
PAR:ARAMI
|
FR |
|
Healthia Ltd
ASX:HLA
|
AU |
|
I
|
Invincible Investment Corp
TSE:8963
|
JP |
|
ACWA Power Co
SAU:2082
|
SA |
|
P
|
PharmaResearch Co Ltd
KOSDAQ:214450
|
KR |
|
Vera Bradley Inc
NASDAQ:VRA
|
US |
|
Endava PLC
NYSE:DAVA
|
UK |
Bankruptcy Probability
Finch Therapeutics Group Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Finch Therapeutics Group Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Finch Therapeutics Group Inc
OTC:FNCH
|
12m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
397.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
191.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
156.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
64.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
38.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Finch Therapeutics Group Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Finch Therapeutics Group Inc has no debt.
You can find a full breakdown on its Balance Sheet.
